Literature DB >> 9886389

TCR activation inhibits chemotaxis toward stromal cell-derived factor-1: evidence for reciprocal regulation between CXCR4 and the TCR.

J W Peacock1, F R Jirik.   

Abstract

Stromal cell-derived factor-1 (SDF-1), a C-X-C family chemokine, is a potent T lymphocyte chemoattractant. We investigated the effects of T cell activation on the chemotactic response to SDF-1. Anti-CD3 Ab stimulation of either Jurkat T cells or murine peripheral CD4+ T lymphocytes produced a dramatic inhibition of SDF-1-induced chemotaxis. In contrast, the SDF-1 responses of Jurkat clones with deficiencies in key TCR signaling components (Lck, CD45, and TCR-beta), were only marginally reduced by anti-CD3 stimulation. Similar to PMA treatment, which abolished both CXCR4 receptor expression and the chemotactic response of Jurkat cells to SDF-1, anti-CD3 Ab treatment reduced cell surface expression of CXCR4 to 65% of the control value, an effect that was blocked by protein kinase C inhibitors. Our data suggest that initial T cell activation events inhibit the response of Jurkat T cells to CXCR4 stimulation. In contrast, SDF-1 treatment resulted in a reduction of tyrosine phosphorylation of the TCR downstream effectors, ZAP-70, SLP-76, and LAT (linker for activation of T cells), suggesting that this chemokine potentially regulates the threshold for T cell activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9886389

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

Review 1.  Imaging T-cell antigen recognition and comparing immunological and neuronal synapses.

Authors:  E Donnadieu; P Revy; A Trautmann
Journal:  Immunology       Date:  2001-08       Impact factor: 7.397

2.  T cell homeostasis requires G protein-coupled receptor-mediated access to trophic signals that promote growth and inhibit chemotaxis.

Authors:  Ryan M Cinalli; Catherine E Herman; Brian O Lew; Heather L Wieman; Craig B Thompson; Jeffrey C Rathmell
Journal:  Eur J Immunol       Date:  2005-03       Impact factor: 5.532

Review 3.  Regulation of CXCR4 signaling.

Authors:  John M Busillo; Jeffrey L Benovic
Journal:  Biochim Biophys Acta       Date:  2006-11-10

4.  CXCR3-mediated T-cell chemotaxis involves ZAP-70 and is regulated by signalling through the T-cell receptor.

Authors:  Wasim A Dar; Stuart J Knechtle
Journal:  Immunology       Date:  2007-01-22       Impact factor: 7.397

Review 5.  Modulation of chemokine receptor activity through dimerization and crosstalk.

Authors:  C L Salanga; M O'Hayre; T Handel
Journal:  Cell Mol Life Sci       Date:  2009-04       Impact factor: 9.261

6.  SDF-1alpha is a potent inducer of HIV-1-Specific CD8+ T-cell chemotaxis, but migration of CD8+ T cells is impaired at high viral loads.

Authors:  Amie L Meditz; Rick Schlichtemeier; Joy M Folkvord; Monique Givens; Kevin C Lesh; M G Ray; Martin D McCarter; Elizabeth Connick
Journal:  AIDS Res Hum Retroviruses       Date:  2008-07       Impact factor: 2.205

7.  Suppression of CXCR4 expression in mast cells upon IgE-mediated antigen stimulation.

Authors:  Junji Matsuura; Mariko Sakanaka; Norio Sato; Atsushi Ichikawa; Satoshi Tanaka
Journal:  Inflamm Res       Date:  2009-08-21       Impact factor: 4.575

8.  CXCL12 induction of inducible nitric oxide synthase in human CD8 T cells.

Authors:  Jonathan C Choy; Tai Yi; Deepak A Rao; George Tellides; Karen Fox-Talbot; William M Baldwin; Jordan S Pober
Journal:  J Heart Lung Transplant       Date:  2008-12       Impact factor: 10.247

9.  T cell specific adapter protein (TSAd) interacts with Tec kinase ITK to promote CXCL12 induced migration of human and murine T cells.

Authors:  Tone Berge; Vibeke Sundvold-Gjerstad; Stine Granum; Thorny C B Andersen; Gunn B Holthe; Lena Claesson-Welsh; Amy H Andreotti; Marit Inngjerdingen; Anne Spurkland
Journal:  PLoS One       Date:  2010-03-18       Impact factor: 3.240

10.  SKAP1 is dispensable for chemokine-induced migration of primary T-cells.

Authors:  Hongyan Wang; Yuning Lu; Christopher E Rudd
Journal:  Immunol Lett       Date:  2009-10-31       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.